BISCAGLIA, Simone
 Distribuzione geografica
Continente #
NA - Nord America 8.281
AS - Asia 5.051
EU - Europa 2.954
SA - Sud America 962
AF - Africa 104
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 17.392
Nazione #
US - Stati Uniti d'America 8.034
SG - Singapore 2.223
CN - Cina 1.233
BR - Brasile 811
DE - Germania 698
HK - Hong Kong 517
IT - Italia 506
GB - Regno Unito 317
VN - Vietnam 315
FI - Finlandia 308
PL - Polonia 201
TR - Turchia 190
FR - Francia 173
SE - Svezia 160
UA - Ucraina 157
RU - Federazione Russa 143
ID - Indonesia 124
CA - Canada 115
IN - India 114
MX - Messico 110
JP - Giappone 71
AR - Argentina 56
ES - Italia 54
ZA - Sudafrica 54
NL - Olanda 52
BD - Bangladesh 38
BE - Belgio 36
AT - Austria 35
AU - Australia 35
KR - Corea 33
IQ - Iraq 30
CO - Colombia 26
IR - Iran 24
EC - Ecuador 23
LT - Lituania 23
PK - Pakistan 21
EG - Egitto 18
CZ - Repubblica Ceca 16
CH - Svizzera 15
MY - Malesia 14
VE - Venezuela 12
TH - Thailandia 11
TW - Taiwan 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
IL - Israele 9
PY - Paraguay 9
CL - Cile 8
IE - Irlanda 8
PT - Portogallo 8
KE - Kenya 7
PE - Perù 6
PS - Palestinian Territory 6
SA - Arabia Saudita 6
TN - Tunisia 6
UY - Uruguay 6
CY - Cipro 5
DK - Danimarca 5
JM - Giamaica 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
HR - Croazia 4
JO - Giordania 4
MA - Marocco 4
RO - Romania 4
BG - Bulgaria 3
BH - Bahrain 3
DZ - Algeria 3
KG - Kirghizistan 3
KW - Kuwait 3
LI - Liechtenstein 3
LV - Lettonia 3
NI - Nicaragua 3
NO - Norvegia 3
PA - Panama 3
PH - Filippine 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MK - Macedonia 2
NP - Nepal 2
OM - Oman 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
AQ - Antartide 1
BB - Barbados 1
Totale 17.374
Città #
Ashburn 1.159
Singapore 1.159
Fairfield 754
Woodbridge 562
Hong Kong 497
Beijing 459
Santa Clara 443
Houston 441
Munich 441
Chandler 334
Seattle 316
Ann Arbor 298
Wilmington 289
Cambridge 265
Dallas 242
Los Angeles 225
New York 200
Warsaw 189
Helsinki 183
Jacksonville 183
Ho Chi Minh City 110
São Paulo 102
Shanghai 98
Princeton 96
Izmir 94
Milan 89
Jakarta 83
Nanjing 82
London 80
Ferrara 75
Turku 71
San Diego 64
Mexico City 61
Tokyo 60
Chicago 59
Hanoi 54
Brooklyn 51
Orem 50
Atlanta 43
Stockholm 43
Denver 39
Frankfurt am Main 39
Boston 38
Buffalo 38
Chennai 38
Montreal 38
Hefei 37
Brussels 36
Nuremberg 36
Johannesburg 34
Poplar 34
Moscow 32
Mumbai 31
Boardman 30
Bremen 29
Falls Church 28
Toronto 28
Phoenix 27
Tianjin 25
San Francisco 24
Manchester 22
Nanchang 22
Rio de Janeiro 22
The Dalles 22
Salt Lake City 21
Amsterdam 19
Ankara 19
Redwood City 19
Columbus 18
Melbourne 18
Bologna 17
Council Bluffs 17
Shenyang 17
Belo Horizonte 16
Des Moines 16
Jiaxing 16
Norwalk 16
Querétaro 16
Changsha 15
Dong Ket 15
Redondo Beach 15
Washington 15
Falkenstein 14
Haiphong 14
Hebei 14
Augusta 13
Biên Hòa 13
Da Nang 13
Jyväskylä 13
Ottawa 13
Assago 12
Brasília 12
New Delhi 12
Paris 12
Addison 11
Bangkok 11
Quito 11
Curitiba 10
Guangzhou 10
Baghdad 9
Totale 11.375
Nome #
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 385
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 375
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 336
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 298
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 280
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 255
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 253
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 237
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 234
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 230
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 230
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 226
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 225
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 207
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 205
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 204
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 201
Uric acid and coronary artery disease: An elusive link deserving further attention 200
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 196
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 194
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 187
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Can we improve myocardial protection during ischaemic injury? 186
Angina and left ventricular dysfunction: can we "reduce' it? 181
BRS implantation in long lesions requiring device overlapping: Myth or reality? 179
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 179
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 178
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 176
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 175
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 174
Reperfusion Damage - A Story of Success, Failure, and Hope 171
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 170
Fractional flow reserve: Current applications and overview of the available data 169
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 169
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 165
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 159
Angina and chronic obstructive pulmonary disease: facing the perfect storm 156
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 154
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 153
Fractional flow reserve implementation in daily clinical practice: A European survey 152
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 152
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 151
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 147
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 146
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 145
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 144
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 142
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry 141
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 140
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 139
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 132
Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis: A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) 131
Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system 131
Transradial coronary catheterization and intervention across the whole spectrum of Allen test results 131
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 130
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 129
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 126
Enhanced stent visualization systems during PCI: A case series and review of literature 124
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) Registry 123
Remodelling after an Infarct: Crosstalk between Life and Death 123
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 122
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 122
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 121
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 121
Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy 119
Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease 119
Functional Assessment and Acute Coronary Syndrome 117
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 115
Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies 114
Seven french radial artery access for PCI: A prospective single-center experience 113
Age and Outcomes in TAVR Patients: Are We Barking Up the Wrong Tree? 110
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 109
#FullPhysiology: a systematic step-by-step guide to implement intracoronary physiology in daily practice 107
Coronary Computed Tomography Angiography for the Assessment of Sirolimus-Eluting Resorbable Magnesium Scaffold 107
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 107
Meta-Analyses on DAPT Length: Chasing the Calm After the (Perfect) Storm 107
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 107
Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19 105
Clinical Outcome of FFR-Guided Revascularization Strategy of Coronary Lesions: The HALE-BOPP Study 102
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 101
Neural interfaces to monitor Interventional Cardiologists' mental workload: GAME-ON SAGA 100
30-Day DAPT in Patients at High Bleeding Risk Undergoing PCI With Biodegradable-Polymer Sirolimus-Eluting Ultra-Thin Stent 97
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 95
Extracorporeal Circulatory Support in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis 95
Complete vs. culprit-only strategy in older MI patients with multi-vessel disease 94
null 94
QFR for the Revascularization of Nonculprit Vessels in MI Patients: Insights From the FIRE Trial 93
The impact of periprocedural myocardial infarction on mortality in older adults with non-ST-segment elevation acute coronary syndrome: a pooled analysis of the FRASER and HULK studies 92
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 91
Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study 91
"Safe Femoral" Artery Approach in Endovascular Procedures: A Systematic Review of Its Safety and Feasibility 89
What are the recommendations for adding novel oral anticoagulants to P2Y12-receptor inhibitors, with or without aspirin? 87
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 86
Long-term outcomes of patients treated with sirolimus-eluting resorbable magnesium scaffolds: Insights from the SHERPA-MAGIC study 85
Comparison of quantitative flow ratio, Pd/Pa, and diastolic hyperaemia-free ratio vs. fractional flow reserve in non-culprit lesion of patients with non-ST-segment elevation myocardial infarction 84
Combined use of intra-aortic balloon pump and impella in cardiogenic shock: A systematic review 82
CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR THE ASSESSMENT OF SIROLIMUS-ELUTING RESORBABLE MAGNESIUM SCAFFOLD 82
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction 81
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial 81
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction With or Without ST-Segment Elevation 81
Totale 15.142
Categoria #
all - tutte 91.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021833 0 0 0 0 0 79 66 167 62 174 192 93
2021/20221.041 106 96 78 43 46 58 56 72 45 78 124 239
2022/2023876 105 55 50 69 128 120 69 72 120 8 58 22
2023/2024899 48 68 36 19 64 147 53 96 23 59 76 210
2024/20254.596 112 104 281 238 507 449 338 270 820 451 565 461
2025/20266.025 1.045 464 1.003 1.403 1.663 447 0 0 0 0 0 0
Totale 17.837